Free Delivery Over $100
|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Patrick Arbuthnot (University of Witwatersrand, Witwatersrand, South Africa)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Dimensions: Width: 19.10cm , Height: 2.30cm , Length: 23.50cm Weight: 1.040kg ISBN: 9780124105188ISBN 10: 0124105181 Pages: 392 Publication Date: 24 June 2015 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Manufactured on demand  We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationPatrick Arbuthnot is currently a personal professor and director of the Antiviral Gene Therapy Research Unit at the University of the Witwatersrand in Johannesburg, South Africa. After completing a medical degree and then a PhD, he carried out post-doctoral research on gene therapy for liver diseases at Necker Hospital in Paris. For more than ten years, his primary research focus has been on advancing gene silencing and gene editing technologies to develop improved treatment of chronic hepatitis B virus infection. In addition, he has worked on furthering methods of disabling genes of HIV-1, Rift Valley Fever virus and hepatitis C virus. Dr Arbuthnot has been an author of numerous publications and edited scientific books on topics related to antiviral gene therapy. Tab Content 6Author Website:Countries AvailableAll regions |
||||
